One-Legged vs Two-Legged Cycle Training for Idiopathic Pulmonary Fibrosis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if exercising one leg at a time can improve exercise endurance in people with idiopathic pulmonary fibrosis (IPF) more effectively than using both legs simultaneously. IPF is a lung disease that makes deep breathing difficult, limiting workouts. Participants will either engage in one-legged cycle training (also known as 1-leg cycle training) or follow the usual two-legged cycling routine to identify the more effective method. Ideal candidates for this trial have confirmed IPF, are stable in their condition, and are already participating in a pulmonary rehabilitation program. As an unphased trial, this study allows participants to contribute to innovative research that could enhance exercise strategies for IPF patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this training method is safe for patients with idiopathic pulmonary fibrosis?
Previous studies have shown that participants tolerate one-legged cycling well. Research indicates that this method can ease breathing during exercise, which benefits people with idiopathic pulmonary fibrosis (IPF). This approach means that even during exercise, the lungs exert less effort than when using both legs. Participants who engaged in one-legged cycling doubled their exercise output compared to using both legs, without serious side effects.
Training focuses on one leg at a time, distributing the effort and aiding those with breathing difficulties. Earlier studies have found this method improves exercise ability and appears safe. No major negative effects have been reported with this type of exercise training.12345Why are researchers excited about this trial?
Researchers are excited about the one-legged cycle training for idiopathic pulmonary fibrosis because it offers a novel way to boost aerobic conditioning. Unlike the standard two-legged cycling, this method isolates each leg, potentially allowing for more targeted muscle engagement and improved endurance over time. By focusing on one leg at a time, participants can gradually increase intensity and duration, which might lead to better cardiovascular improvements and overall exercise tolerance, a crucial factor for individuals with this lung condition.
What evidence suggests that this trial's treatments could be effective for idiopathic pulmonary fibrosis?
This trial will compare one-legged cycle training with two-legged cycle training for individuals with idiopathic pulmonary fibrosis (IPF). Research has shown that cycling with one leg can greatly improve exercise performance in people with IPF. Studies have found that participants produce twice the work output when using one leg instead of both. This technique eases breathing by engaging fewer muscles at a time. Additionally, cycling with one leg can lead to better physical improvements over time. For those with lung conditions like IPF, this could result in better endurance and easier workouts.12367
Who Is on the Research Team?
Roger Goldstein, MD, FRCPC
Principal Investigator
West Park Healthcare Centre
Are You a Good Fit for This Trial?
This trial is for stable patients with confirmed idiopathic pulmonary fibrosis who are enrolled in a pulmonary rehab program. It's not suitable for those who've had a recent exacerbation, finished rehab within the last 6 months, or have other health issues that could make rehab unsafe.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo partitioned aerobic exercise training with either one-legged or two-legged cycle training for 8 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- 1-leg cycle training
- 2-leg cycle training
Find a Clinic Near You
Who Is Running the Clinical Trial?
West Park Healthcare Centre
Lead Sponsor